Exelixis (EXEL) EBT Growth (1y) (2011 - 2026)
Exelixis (EXEL) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 30.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 30.14% |
| Jan 2, 2026 | 36.76% |
| Oct 3, 2025 | 63.10% |
| Jul 4, 2025 | -21.32% |
| Apr 4, 2025 | 317.50% |
| Jan 3, 2025 | 79.32% |
| Sep 27, 2024 | 2,559.93% |
| Jun 28, 2024 | 191.72% |
| Mar 29, 2024 | 2.05% |
| Dec 29, 2023 | 427.87% |
| Sep 29, 2023 | -93.68% |
| Jun 30, 2023 | 13.42% |
| Mar 31, 2023 | -43.35% |
| Dec 30, 2022 | -126.63% |
| Sep 30, 2022 | 72.82% |
| Jul 1, 2022 | -29.13% |
| Apr 1, 2022 | 4,329.73% |
| Dec 31, 2021 | 164.75% |
| Oct 1, 2021 | 240.08% |
| Jul 2, 2021 | 54.76% |